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Introduction.
Polymerase chain reaction (PCR) is a molecular based tech-
nique. It derives its name from one of its key components, 
DNA polymerase, which is used to amplify a piece of DNA 
by in vitro enzyme-mediated replication. As PCR progres-
ses, the DNA thus generated is itself used as template for 
replication. This in turn will set in motion a chain reaction 
in which the DNA template is exponentially amplified. The 
technique can be used to amplify single or few genomic co-
pies of a target, which would otherwise remain undetected. 
A key component for this process is a pair of primers, which 
are composed of oligonucleotides (about 20 nucleotides in 
length); these are complementary to a pre-defined sequen-
ce on both the forward and reverse strands of DNA. The 
same primers can be used again and again, to make other 
copies of the target sequence. A revolutionary step in the 
process was the discovery of a thermo-stable DNA polyme-
rase, Taq polymerase, from Thermophilus aquaticus a bac-
terium that can withstand extreme temperatures, allowing 
the reaction to continue without the addition new polyme-
rase in every round of the process. For conventional PCR, 
35 cycles of amplification are usually carried out, and the 
product can be visualized in the form of “bands” on agaro-
se gel. This is a qualitative approach, as often the amount 
of product is not related to the amount of input DNA.
Real time-PCR (RT-PCR), a technique that follows the gene-
ral basics of conventional PCR however it allows the measu-
rement of PCR products in real time as the reaction progres-
ses. Reverse transcriptase PCR analysis of RNA, which can 
also mistakenly be abbreviated as “RT-PCR”, is an analysis 
to measure RNA. Here RNA is copied to complementary DNA 
(cDNA) by reverse transcriptase. This product the is ampli-
fied by PCR allowing the formation of a second strand of 
DNA, which can be further amplified and eventually analy-
zed conventionally or in real time. In this review the abbre-
viation RT-PCR represents real-time PCR.
Processes and Principles of RT-PCR.
Nucleic acid extraction processes
There are many different commercial platforms available for 
nucleic acid extraction. The choice of extraction platform 
will depend on the needs of the laboratory in terms of 
the quantity of samples received. Low, medium and high 
throughput automated extraction platforms can be widely 
found from most companies, which can be used to process 
up to 96 samples in one extraction run. In most cases the 
chemistry for RNA (as RNA is less stable, reagents are added 
to stabilize the extracted nucleic acid) and DNA extraction 
will differ but the extraction process will remain the same. 
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Figure 1. The principle of RT-PCR with dual labeled probe containing a 
flurophor on one end and a quencher molecule on the other.
The extraction process usually begins by lysing the cells of 
the target organism using enzymes such as proteinase K. 
Once lysed, the nucleic acid can then be bound to a mem-
brane or to glass beads which are then washed several ti-
mes to remove any possible inhibitors that may be present 
in the original sample and the remaining enzymes used for 
lysis. Once washing is complete, the nucleic acid can then 
be eluted off in to a clean collection tube. This extract is 
then ready for PCR. At this stage the eluate can be stored at 
-20°C for a short period of time if PCR is not planned imme-
diately. Manual extraction processes also follow the same 
format of lysing, binding, washing and eluting.1-3 
Principles of RT-PCR
As with conventional PCR, in RT-PCR, double strand DNA (ds-
DNA) is denatured at approximately 95°C, this high tempe-
rature breaks the hydrogen bonds that bind one side of the 
helix to the other allowing the two strands separate. The 
sample is cooled to between 50 to 60°C to allow annealing 
of primers that are complementary to a specific site on each 
strand. The temperature is raised to 72ºC and the addition 
of the heat-stable Taq polymerase extends the DNA from 
the primers generating four cDNA strands. A major improve-
ment in this system is the addition of a dual labeled probe, 
which contains a flurophor on one end and a quencher 
molecule on the other. The shape of the un-bound probe 
allows the flurophor and quencher molecules to sit in close 
proximity to each other preventing the premature release 
of fluorescence. After each cycle, the level of fluorescence 
released is measured when bound to the ds-DNA i.e. the 
PCR product. The progress of PCR amplification can be con-
tinuously monitored in real time by acquiring fluorescence 
signals in each amplification reaction cycle. Thus, after 30 
to 40 cycles, quantitative information of the PCR process is 
obtained by plotting the intensity of the fluorescence signal 
versus cycle number (Figure 1 and 2). Automated assays 
are relatively easy to perform and they are not only valua-
ble in reducing chances of contamination, but also enable 
reproducibility and rapid processing of multiple samples 
Duplex, triplex and multiplex RT-PCRs are reactions in which 
two, three or more fluorogenic probes are used simulta-
neously for the discrimination of multiple amplicons in a 
single tube. These reactions are possible because probes 
labeled with fluorescent dyes with different excitation and 
emission spectra allowing each target to me measured in-
dependently of the others.  The main advantages of multi-
plexing over single-target analysis are the ability to provide 
internal controls, lower reagent costs and preservation of 
precious samples. The introduction of combinatorial fluo-
rescence energy transfer tags is important in boosting the 
development of multiplex real-time PCR.4
There are two quantifications types from RT-PCR,5-7 one of 
which is an absolute quantification that requires an input 
standard curve with series diluted template (five- or tenfold 
serial dilution). This curve is used as a reference standard 
for extrapolating quantitative information for target nucleic 
acid. Using the known copy level of the standard reagent, 
the software of the PCR instrument generates a standard 
curve in a plot that relates fluorescence (measure of am-
plified product) and the cycle number in which the nucleic 
acid target is detected. This method determines the abso-
lute amount of a target (expressed as copy number or con-
centration), which is one of the most accurate standards for 
gene expression analysis.
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Figure 2. Graphic representation of RT-PCR quantitative plot after 40 cycles, quantitative information of the 
PCR process is obtained by plotting the intensity of the fluorescence signal versus cycle number.
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Relative quantification, also known as the comparative 
threshold Method determines the ratio between the amount 
of target and an endogenous reference gene, usually a sui-
table housekeeping gene, that are not expected to change 
under the experimental conditions serve as a convenient 
internal standard. This normalized value can then be used 
to compare, for example, differential gene expression in 
different samples. The target and the reference genes are 
amplified from the same sample, either separately or in 
the same reaction (duplex RT-PCR). The normalized value is 
determined for each sample and can be used to compare, 
for example, differential expression of a gene in different 
tissues. Because the absolute quantity of the internal stan-
dard is not known, only relative changes can be determined 
by this method. If a housekeeping gene cannot be found 
whose amplification efficiency is similar to the target, then 
the standard curve method should be used.
Chemistries, Instrumentations, Designs and 
Reagents of RT-PCR.
Chemistries of RT-PCR
The key to real-time PCR is the ability to monitor amplifica-
tion as it occurs. This is accomplished by specific chemis-
tries and instrumentation. Generally, chemistries consist 
of special fluorescent probes in the PCR. Several types of 
probes exist, including DNA-binding dyes like SYBR green I 
which intercalate in to the ds-DNA as it is formed, hydro-
lysis probes (5_-nuclease probes), hybridization probes, 
molecular beacons, sunrise and scorpion primers, and pep-
tide nucleic acid (PNA) light-up probes. Each type of probe 
has its own unique characteristics, but the strategy is they 
must link a change in fluorescence to amplification of DNA.
One class of RT-PCR chemistry uses different fluorescent 
dyes incorporated in short oligonucleotide probes specific 
for the amplified target. Another class consists of dyes that 
bind ds-DNA and become fluorescent; the most commonly 
used of these is SYBR Green I.8 SYBR Green I fluorescence 
is enormously increased upon binding to the minor groove 
ds-DNA. As it is an intercalating fluorescent dye, during the 
extension phase, more and more SYBR Green I will bind to 
the PCR product, resulting in an exponential rise on fluo-
rescence. Consequently, during each subsequent PCR cycle 
more fluorescence signal will be detected. The technique 
is inexpensive and generic, as it requires the same detec-
tion reagent for each template to be tested. But detection 
with dyes like SYBR Green I are less specific than probe-
based detection methods. In addition, SYBR Green I cannot 
be used in multiplexed assays. The benefit of using this 
type of assay in a non clinical setting is to investigate the 
possibility of contamination during the validation process. 
This method can be used to visualize the melting tempera-
tures of various targets that may have been inadvertently 
introduced in to the PCR mix as they are likely to have a 
different melting temperature to the actual target in ques-
tion. This process can replace the laborious task of pouring 
and running conventional gels to look for contamination. It 
is worth noting that SYBR Green is not commonly used in 
routine clinical practice.   
Hydrolysis probe technique: Addressing the specificity pro-
blem, these are sequence-specific and conjugated with a 
quencher fluorochrome, which absorbs the fluorescence of 
the reporter fluorochrome on condition that the probe is 
intact. However, upon amplification of the target sequen-
ce, the hydrolysis probe is displaced and subsequently 
hydrolyzed by the Taq polymerase. This results in the se-
paration of the reporter and quencher fluorochrome and 
consequently the fluorescence of the reporter fluorochrome 
becomes detectable. Throughout the PCR cycles this fluo-
rescence will further increase because of the progressive 
and exponential buildup of free reporter fluorochromes.1 
This allows results to be visualized in real-time which in a 
clinical setting can be important. 
TaqMan probes depend on the 5’- nuclease activity of the 
DNA polymerase used for PCR to hydrolyze an oligonucleo-
tide that is hybridized to the target amplicon. The probe 
has a fluorescent reporter dye attached to its 5´ end and 
a quencher dye at its 3´ terminus. If the target sequen-
ce is present, the fluorogenic probe anneals downstream 
from one of the primer sites and is cleaved by the 5´ nu-
clease activity of the Taq polymerase enzyme during the 
extension phase of the PCR. Whilst the probe is intact, 
fluorescence resonance energy transfer (FRET) occurs and 
the fluorescence emission of the reporter dye is absorbed 
by the quenching dye. During PCR, when the polymerase 
replicates a template on which a TaqMan probe is bound, 
the 5’- nuclease activity of the polymerase cleaves the pro-
be. This separates the reporter and quencher dyes, thereby 
increasing the fluorescence from the former, which has a 
linear relationship with the amount of probe cleavage. Well-
designed TaqMan probes require very little optimization, 
and can be used for multiplex assays. There are several 
other variations on the reporter-quencher theme, including 
molecular Beacons, sunrise primers, and scorpion primers. 
It is possible to convert a monoplex assay in to a sequence 
of multiplex assays allowing more than one target to be 
identified in one single reaction. This is important in a cli-
nical setting especially when dealing with samples such as 
cerebrospinal fluid which are difficult to collect and often 
come in small volumes. Each extraction may only elute as 
little as 50µl so being the ability to test multiple targets 
whilst using the minimal amount of eluted nucleic acid is 
an advantage.  
Hybridization probes technique: In this technique one pro-
be is labelled with a donor fluorochrome at the 3’ end and 
a second –adjacent- probe is labeled with an acceptor fluo-
rochrome. When the two fluorochromes are in close vicinity 
(1–5 nucleotides apart), the emitted light of the donor fluo-
rochrome will excite the acceptor fluorochrome FRET. This 
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results in the emission of fluorescence, which subsequently 
can be detected during the annealing phase and first part 
of the extension phase of the PCR reaction. After each sub-
sequent PCR cycle more hybridization probes can anneal, 
resulting in higher fluorescence signals. This method is wi-
dely been used for detection of minimal residual disease 
after treatment and viral load quantification.1 
Instrumentation of RT-PCR
The chemistries and instrumentation of RT-PCR are closely 
connected. The instrumentations that are required for RT-
PCR technique consists of a thermal cycler for amplification, 
a light source for excitation of fluorescent probes, a camera 
for recording, and a computer to control instruments and 
record data. Because fluorescent chemistries require both a 
specific input of energy for excitation and a detection of a 
particular emission wavelength, the instrumentation must 
be able to do both simultaneously and at the desired wave-
lengths. Scientists can be faced with a daunting task when 
selecting platforms as machines are available from several 
manufacturers, with difference in sample capacity (e.g. 96-
well standard format, some require specialized glass capi-
llary tubes), methods of excitation, some use lamp (broad-
spectrum emission devices), light-emitting diode (LED), or 
laser (narrow spectrum), and overall sensitivity. There are 
also platform-specific differences in how the software pro-
cesses data. Emission energies must also be detected, by 
cameras or other types of photodetectors, at the appropria-
te wavelengths in order to collect appropriate data. Narrow 
wavelength filters or channels are generally employed to 
allow only the desired wavelength(s) to pass to the pho-
todetector to be measured. The detector and the capability 
of the instrument for distinguishing different wavelength 
signals can influence the level of assay and allows for mul-
tiplexing.
Efficient performance of quantitative PCR requires rapid, 
precise, thermal control. Hence, the significance of the ther-
mocycler in RT-PCR is in its ability to maintain a consistent 
temperature among all sample wells, as any differences in 
temperature could lead to erroneous PCR amplification effi-
ciencies. The temperature uniformity has a direct impact on 
the ability to discriminate between different PCR products 
by performing melting point analysis. Additionally, the re-
solution with which instruments are able to control tem-
perature is a major factor, which affects their performance 
when performing high resolution melting analysis. Thermal 
non-uniformity during temperature cycling contributes to 
variability in PCR and can affect the RT-PCR accuracy. This 
can be solved by using a heating block, heated air, or a 
combination of the two. It is important to ask respective 
manufacturers to provide up to date information on the 
platform you chose to purchase for your facility. To ensure 
consistent analysis and reporting of results, suitable com-
puter hardware, data-acquisition and analysis software are 
essential to complete the process.9 
Design of RT-PCR Assays and reagents used 
PCR cannot take place without a number of specific rea-
gents, that include; 
•	 DNA template that contains the DNA region (target) 
to be amplified. 
•	 Two primers, which are complementary to the DNA 
regions at the 5’ (five prime) or 3’ (three prime) ends 
of the DNA region. 
•	 DNA or Taq polymerase.
•	 Deoxynucleoside triphosphates (dNTPs; also very 
commonly and erroneously called deoxynucleotide 
triphosphates), the building blocks from which the 
DNA polymerases synthesizes a new DNA strand. 
•	 Buffer solution, providing a suitable chemical envi-
ronment for optimum activity and stability of the DNA 
polymerase. 
•	 Divalent cations, magnesium or manganese ions; ge-
nerally Mg2+ is used, but Mn2+ can be utilized for PCR-
mediated DNA mutagenesis, as higher Mn2+ concen-
tration increases the error rate during DNA synthesis.
•	 Monovalent cation potassium ions.
The PCR is commonly carried out in a reaction volume of 
20-150 µl in small reaction tubes (0.2-0.5 ml volumes) in a 
thermal cycler. The thermal cycler heats and cools the reac-
tion tubes to achieve the temperatures required at each 
step of the reaction (see below). Many modern thermal 
cyclers make use of the Peltier effect which permits both 
heating and cooling of the block holding the PCR tubes sim-
ply by reversing the electric current. Thin-walled reaction 
tubes permit favorable thermal conductivity to allow for ra-
pid thermal equilibration. Most thermal cyclers have heated 
lids to prevent condensation at the top of the reaction tube. 
The efficacy of RT-PCR is determined by its specificity, low 
background fluorescence, steep fluorescence increase, high 
amplification efficiency, and high level plateau.10-13
Contamination Prevention and Control in the 
PCR Laboratory.
Contamination remains an issue for laboratories performing 
detection of microbes using PCR. RT-PCR processing can be 
classified into two major groups, the pre-PCR stage (inclu-
ding preparation of both the sample and PCR reagents) 
and post-PCR (PCR execution and analysis). Compliance 
with guidelines to prevent contamination is essential for 
successfully operating a PCR laboratory on a long-term ba-
sis. Guidelines must be part of a network of protocols or 
standard operating procedures focused on maintaining a 
contamination- free zone in the laboratory. Contamination 
sources vary, e.g. one of the most frequent causes of PCR 
product contamination is the generation of aerosols of PCR 
amplicons that is associated with the post-PCR analysis. 
Other sources include previous procedures and amplified 
molecules (“amplicons”). Purification of plasmid clones, 
repeated isolation of template nucleic acids should not be 
ignored as potential sources; DNA templates are typically 
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more troublesome as contaminants because they are more 
stable than RNA targets. There are a number of approa-
ches to control of PCR contamination, and the stringency 
that is required in a laboratory is invariably determined by 
the assay being performed. A practical approach to con-
trol contamination is to segregate activities and limit the 
performance of PCR activities to its own area. The crucial 
steps in preventing, eliminating or controlling contamina-
tion include separation of pre- and post-PCR procedures, 
utilization of physical barrier approaches e.g. maintaining 
a unidirectional flow of work in the laboratory, the use of 
barrier pipette tips to prevent aerosols generation, or use of 
chemical means e.g. use of ultraviolet photolinking, use of 
aliquoted PCR reagents, incorporation of numerous positive 
and negative or blank PCRs (H
2
O substituted for template), 
and use of Uracil-DNA-glycosylase (UDG) an enzyme effec-
tive at destroying PCR amplicons when vigorously used for 
sample preparation. Use of consistent, careful technique by 
the operator coupled with monitoring of PCR controls will 
ensure a proactive approach to PCR contamination. 
Troubleshooting in RT-PCR.
Poor PCR amplification efficiency with little or no PCR pro-
duct
This can often be caused by poor quality oligonucleotides, a 
badly extracted sample (resulting in poor quality template), 
insufficient sample (where the nucleic acid may be too di-
luted to be detected) or by expired or poor quality reagents 
that are not suitable for the RT-PCR platform. It is necessary 
to include both positive and negative controls as well as 
an extracted internal positive control in order to determine 
both the extraction efficiency and the presence of inhibitors 
in the sample and the efficiency of the PCR.  
Primer dimers
Can be observed when gene expression is low and can be 
easily resolved by increasing concentration of the target 
template. Primers that have been designed to be less than 
24 base pairs long and which are not rich in “GC” content, 
ensuring that there are no more than three “G’s” together 
and also preventing the use of “G” oligonucleotides at the 
5’ end often will help to prevent the formation of primer 
dimers (Figure 3).  
Non-specific amplicons, multiple bands or multiple peaks 
in the melting curve
The presence of spurious bands in both melt curve analysis 
and agarose gel electrophoresis is most likely to occur due 
to poor assay optimisation. In this case it is advisable to 
investigate further both the cycling conditions (non specific 
binding can occur if the annealing/extension temperature 
in a “two step” PCR is far lower than the combined melting 
temperature of both the primers and probe) and chemistry 
of the assay. It is also necessary to “check” the oligonucleo-
tide sequences to ensure that those selected are common 
only to the target organism.
Advantages and Limitations of RT-PCR .
RT-PCR has the ability to quantify nucleic acids over a wide 
dynamic range (7-8 log units). This is coupled to high te-
chnical sensitivity, allowing the detection of less than five 
copies of a target sequence. With appropriate internal 
standards and calculations, mean variation coefficients 
are 1–2%, allowing reproducibility. In addition, all real-time 
platforms are relatively quick, with some affording high-
throughput automation. RT-PCR is performed in a closed 
reaction vessel that requires no post-PCR manipulations, 
thereby minimizing the chances for cross contamination in 
the laboratory. 
Like other diagnostics there are several limitations to RT-
PCR methods. RT-PCR is susceptible to inhibition by com-
pounds present in certain biological samples. Because of 
the necessary use of RNA in an extra enzymatic step, errors 
can occur. RNA itself is extremely labile compared with DNA, 
and therefore isolation must be carefully performed to en-
sure both the integrity of the RNA itself and the removal of 
contaminating nucleases, genomic DNA, and reverse trans-
criptase or PCR inhibitors. This can be a problem with any 
sample source, but clinical samples are of special concern 
because inconsistencies in sample size, collection, storage, 
and transport can lead to a variable quality of RNA templa-
tes. Conversion of RNA to cDNA during the RT reaction is 
also subject to variability because multiple reverse trans-
criptase enzymes with different characteristics exist, and 
different classes of oligonucleotides can be used to prime 
RT. 
Probably the largest present limitation of RT-PCR, howe-
ver, is not inherent in the technology but rather resides in 
Figure 3. Primer dimer can be observed in RT-PCR when gene expression is low and can be easily resolved by 
increasing concentration of the target template.
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Bacillus anthracis spores and for differentiation based on 
virulence encoding plasmids and chromosomal markers.
Some RT-PCR assays may also be useful in deciding on the 
use of antimicrobial agents. The rapid turnaround time of 
RT-PCR can detect and monitor the antibiotic resistance of 
clinical isolates of bacteria such as, enterobacteriacae (e.g. 
Extended spectrum Beta lactamse producers ESBL or Me-
tallo Beta lactamse producers), Staphylococcus aureus, S. 
epidermidis, Helicobacter pylori, Enterococcus faecalis, and 
Enterococcus faecium (Glycopeptide resistant enterococci 
or GRE or VRE). For example, rapid RT-PCR analysis detecting 
rifampin resistance in M. tuberculosis complex, and a RT-
PCR was applied successfully to screen for MRSA from nasal 
swabs and joint fluids.19,20 RT-PCR is becoming one of the 
main tests proposed for multi-step algorithms in testing for 
Clostridium difficile genes in suspected cases with negative 
immuno-assays.21 Another important area is the ability to 
extract E. coli O157:H7 DNA, directly from stool specimens, 
which is not only important for patient management but 
also for prompt epidemiological investigations. A speci-
fic PCR for detecting Neisseria meningitides, Haemophilus 
influenzae, and Streptococcus pneumoniae has provided 
more rapid results than culture, especially where antibio-
tics are administered before samples were obtained.22
RT-PCR can complement histopathological and serological 
analysis, e.g. detection of Bartonella henselae, a difficult 
to culture organism, in patient samples with suspected Cat 
Scratch Disease. As is the case for other fastidious organisms, 
PCR offers an attractive alternative for detecting Bordetella 
pertussis and B. parapertussis in clinical specimens. PCR 
can be used to detect Tropheryma whipplei genes from a 
variety of human specimens, allowing appropriate treatment 
with antibiotics for appropriate duration. Further more, the 
laboratory diagnosis and screening for Borrelia burgdorferi 
(Lyme borreliosis) is currently based on serology which has 
some drawbacks e.g. false negatives mainly during the early 
stages of the infection and false positive results especially 
in some patients with autoimmune disease. PCR on various 
tissues and body fluids, including the CSF, may have the 
potential to be helpful to tackle these issues, however, 
details of patient sample requirements and rapid sample 
preparation techniques remain to be worked out.23-26 
Viruses
Since its discovery, RT-PCR has had a major impact on cli-
nical virology. This is mainly due to the less genetic com-
plexity of these organisms, the lack of rigid cell membranes 
makes it easier to extract nucleic acids from viruses and 
traditionally the effort of conventional culture is great for 
viruses. 
Qualitative Viral Assays have been applied in the diagnosis 
of Herpes simplex virus (HSV), data has shown increased 
detection rates by RT-PCR for up to 300% over cell culture 
methods for diagnosis of HSV infections, with faster tur-
human error: improper assay development, incorrect data 
analysis, or unwarranted conclusions. RT-PCR primer sets 
must be designed and validated by stringent criteria to en-
sure specificity and accuracy of the results. For microbiolo-
gy, false positives or negatives must be considered when 
designing an assay to detect pathogens. Amplification and 
melting curves must be visually inspected while indepen-
dent calculations based on these curves should be double-
checked for accuracy. Of course, conclusions based on data 
derived from RT-PCR are best utilized when the biological 
context is well understood.
Applications of RT-PCR in a Diagnostic Micro-
biology Laboratory.
RT-PCR is widely used across many clinical disciplines for 
example in clinical oncology RT-PCR has been used for the 
detection and quantification of chromosomal transloca-
tions, to monitor minimal residual disease or to show gra-
ft-versus lymphoma effects.14-16 Other applications include 
predictive genetic testing and the identification of relevant 
single nucleotide polymorphisms. Another major area for 
applications of real-time reverse transcriptase RT-PCR as-
says is the quantification of gene expression. 
In this section we would like to concentrate on the appli-
cation of RT-PCR in clinical microbiology where highly con-
served regions of the target organism genome tend to be 
chosen for assay development to avoid detection failure 
especially in agents with high mutation rates. The concern 
is with the emerging infectious agents e.g. severe acute 
respiratory syndrome coronavirus (SARS-CoV), where com-
parative genome investigations should be performed before 
a reliable assay can be developed.1,17,18
Bacteria
Results of RT-PCR assays for detection bacteria can inform 
the clinician of the infection status of the patient more ra-
pidly than culture methods. This is of particular importance 
as in the current era of rising antimicrobial resistance; it 
allows more specific and timely administration of appro-
priate and directed antimicrobial therapy. This will not only 
increase the treatment efficiency but also reduce the time 
of hospitalization, and avoid the inappropriate use of anti-
biotics with unwanted effects. 
PCR has long been the preferred method for diagnosis of 
bacteria that are difficult to culture, and numerous RT-PCR 
assays have already been developed to replace conventional 
PCR methods for bacteria such as Legionella pneumophila 
(which can take up to fourteen days for cultures to grow), 
Chlamydiophilia (which can only be cultured in active 
tissue cell lines) and Mycobacterium spp (can take weeks 
to grow). The method has now become an important tool 
in the rapid detection bacterial pathogens implicated as 
biological weapons.  An excellent example is the successful 
application of RT-PCR for screening for the presence of 
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naround times at equivalent cost.27 Varicella-zoster virus 
(VZV): RT-PCR techniques permit highly sensitive same-day 
detection of VZV in clinical specimens, e.g. in testing CSF 
samples for the diagnosis of VZV meningitis or encephali-
tis. Enteroviruses: Collectively, these viruses are associated 
with diverse clinical manifestations ranging from mild febri-
le illness to aseptic meningitis, encephalitis, myocarditis, 
and poliomyelitis.
Early detection of these agents in clinical samples have 
shown valuable in reducing medical costs incurred by pa-
tients by reducing hospitalization and hospital stays and 
the use of unnecessary antibiotics and antiviral agents.28 
Other applications are in the diagnosis of respiratory Vi-
ruses, including Adenovirus, Influenza virus types A and 
B, Parainfluenza virus, Respiratory syncytial virus (RSV), 
SARS-CoV and Human Metapneumovirus. Rapid laboratory 
diagnosis of influenza is critical for infection control, espe-
cially in hospital and nursing home settings intervention 
with effective antiviral treatment if provided to the patient 
in the early stages of this viral disease.
Conventional techniques e.g. cell cultures, are hazardous 
in some cases e.g. SARS-CoV, because of the risk of labora-
tory-acquired infections with this agent and bio-safety level 
3 laboratory facilities are required for culturing the virus 
Commercial RT-PCR reagents are critical not only for the 
rapid recovery and identification of SARS-CoV, but also for 
reducing transmission to healthcare workers and laboratory 
personnel. RT-PCR using throat or nasopharyngeal samples 
also played a major role in early diagnosis during the 2009-
10 “pandemic” of H1N1 or “swine flu”. These tests have im-
proved the capabilities of hospital and public health labo-
ratories for diagnosing viral respiratory tract infections and 
emerging infections and assisted public health agencies in 
identifying outbreaks and pandemics.29-31
Quantitative Viral Assays have been used to assess the re-
lationship between the viral load (copy level) and the pre-
diction of progression of infection and development of cli-
nical disease. For example in Cytomegalovirus (CMV) using 
serial samples from transplant cases to monitor CMV DNA/
ml, by RT-PCR, have been used to detect evolving sympto-
matic infection or for initiating preemptive antiviral therapy. 
Similarly  quantification of Epstein-Barr Virus (EBV) DNA pro-
vides the potential for the designation of viral load levels 
generally associated with healthy or subclinical carriers of 
EBV (reactivated infection) compared with those levels of 
virus that produce disease states such as post transplant 
lymphoproliferative disorder in transplant patients.32,33 
Human Immunodeficiency Virus (HIV): HIV-1 and HIV-2 RNA 
levels in the plasma of infected individuals can be deter-
mined reliably by quantitative rapid RT-PCR assays. These 
assays will help clinicians in early identification of patients 
who are virologically responding to highly-active antiretro-
viral therapy (HAART) and achieve HIV viral load copies be-
low 50 copies/mL.34,35 There are a number of other assays 
e.g. for Hepatitis B virus which is important for monitoring 
disease progression and for assessing the response to anti-
viral therapy36 and also quantitative 
Hepatitis B virus PCR is been used as a guide employers 
e.g. healthcare workers who are infected with Hepatitis B 
virus in the UK and whose viral load rose above 103 geno-
me-equivalents/ml should are restricted from performing 
exposure prone procedures for as long as their viral load 
remained above that level.37
Parasites, Fungi, and Protozoa
Over the past 20 years, dramatic advancements have oc-
curred in the molecular approach to the investigation of 
parasites and parasitic diseases. RT-PCR methodology has 
been efficiently used to detect, differentiate, and diagno-
se parasites that infect humans and animals. Among pa-
rasitic infections, RT-PCR has been applied most vigorously 
in the diagnosis and detection of drug resistance genes 
of Plasmodium spp - causative agents of malaria. Speci-
fic RT-PCRs have been developed to diagnose Toxoplasma 
gondii, Trypanosoma cruzi, Babesia spp., Leishmania spp., 
Cryptosporidium parvum, Entamoeba, and Giardia spp. The 
traditional culture method, animal inoculation, and serolo-
gical detection are not only time consuming but also lack of 
sensitivities. RT-PCR vastly improved speed and sensitivity 
of diagnosis of such parasites with impact on clinical mana-
gement and epidemiological investigations.38-45
RT-PCR assays can also be successfully applied to the diag-
nosis of diseases caused by Aspergillus fumigatus and A. 
flavus. The rationale behind this effort is that timely detec-
tion of Aspergillus spp. may decrease the extreme morbi-
dity and mortality associated with invasive aspergillosis by 
initiating antifungal therapy in a timely manner, particularly 
in immunocompromised individuals. RT-PCR can also detect 
A. fumigatus mutations that confer high-level resistance to 
antifungals. 
The use of RT-PCR has also been of great use in identifica-
tion of Cryptococcal disease which has become a major fun-
gal infection in patients infected with HIV and AIDS patients. 
In addition PCR has been used in the early identification of 
Pneumocystis jirovecii the causative organism on Pneumo-
cystis pneumonia (PCP). 
High sensitivity of this method makes the assay appealing 
in the identification of this organism in immunocompro-
mised patients which can help clinicians confirming their 
clinical suspicion on the basis of risk factors, Chest-XRay 
findings and pulse oximetry which ultimately leads to early 
initiation of appropriate treatment that in turn can improve 
outcome and shorten the patient’s hospital stay.46-48
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Conclusion.
Numerous technological advances have been made using 
PCR since its discovery in the mid-1980’s. RT-PCR is one 
of the enabling technologies of the genomic era and has 
become the method of choice or the gold standard for the 
detection of nucleic acid. Prior to the development RT-PCR, 
quantitative PCR was very labor intensive. Real-time tech-
nology has significantly extended the use and scope of RT-
PCR assays, with the potential for quantification of nucleic 
acid targets a particular advantage. RT-PCR offers streamli-
ned assay development, reproducible results, and a large 
dynamic range. The focus on nucleic acid quantification, 
together with the introduction of advanced uncomplicated 
instrumentation and chemistries, has facilitated the mi-
gration of this technology from research laboratories into 
individual diagnostic laboratories. Despite some of the diffi-
culties that may still need to be worked out, the foundation 
has been set for the use of quantitative RT-PCR in routine 
diagnostic laboratories. This is reflected in the increasingly 
significant role it plays in clinical diagnosis in infection and 
infectious diseases, in particular when used to determine 
the viral load and disease progression. The technology can 
generate large amounts of data within a relatively short 
time. The accuracy of the obtained data is largely depen-
ded on several factors including; the choice of chemistries, 
primers and probes, and instruments. Appropriate applica-
tion, quality control and standardization are also important 
matters and must be considered, it is vital to take time to 
evaluate each stage of the development protocol, starting 
with laboratory setup, sample acquisition and template 
preparation, and the RT-PCR steps. Only if all of these sta-
ges are appropriately validated is it possible that molecular 
diagnosticians can reliably interpret data to clinical collea-
gues to have the best positive impact on patients’ outcome.
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